NO20003050L - Metode for Õ administrere monomere insulinanaloger - Google Patents

Metode for Õ administrere monomere insulinanaloger

Info

Publication number
NO20003050L
NO20003050L NO20003050A NO20003050A NO20003050L NO 20003050 L NO20003050 L NO 20003050L NO 20003050 A NO20003050 A NO 20003050A NO 20003050 A NO20003050 A NO 20003050A NO 20003050 L NO20003050 L NO 20003050L
Authority
NO
Norway
Prior art keywords
insulin analogues
monomeric insulin
administering monomeric
administering
analogues
Prior art date
Application number
NO20003050A
Other languages
English (en)
Other versions
NO20003050D0 (no
Inventor
Richard Dennis Dimarchi
Roger Garrick Harrison
Ronald Keith Wolff
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20003050D0 publication Critical patent/NO20003050D0/no
Publication of NO20003050L publication Critical patent/NO20003050L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO20003050A 1998-01-08 2000-06-14 Metode for Õ administrere monomere insulinanaloger NO20003050L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7075298P 1998-01-08 1998-01-08
PCT/US1999/000324 WO1999034816A1 (en) 1998-01-08 1999-01-07 Method for administering monomeric insulin analogs

Publications (2)

Publication Number Publication Date
NO20003050D0 NO20003050D0 (no) 2000-06-14
NO20003050L true NO20003050L (no) 2000-06-14

Family

ID=22097181

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20003051A NO20003051L (no) 1998-01-08 2000-06-14 Metode for administrering av AspB28-humant insulin
NO20003050A NO20003050L (no) 1998-01-08 2000-06-14 Metode for Õ administrere monomere insulinanaloger

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20003051A NO20003051L (no) 1998-01-08 2000-06-14 Metode for administrering av AspB28-humant insulin

Country Status (16)

Country Link
US (2) US20010053761A1 (no)
EP (2) EP0951911A3 (no)
JP (2) JP2002500192A (no)
KR (2) KR20010033941A (no)
CN (2) CN1195543C (no)
AU (2) AU747619B2 (no)
BR (2) BR9906813A (no)
CA (2) CA2317733A1 (no)
EA (2) EA200000747A1 (no)
HU (2) HUP0101293A3 (no)
IL (2) IL137150A0 (no)
NO (2) NO20003051L (no)
PL (2) PL342745A1 (no)
TR (2) TR200001892T2 (no)
WO (2) WO1999034815A1 (no)
ZA (2) ZA99105B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
AU5453300A (en) * 1999-06-29 2001-01-31 Eli Lilly And Company Insulin crystals for pulmonary administration
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US7374782B2 (en) 2000-10-27 2008-05-20 Baxter International Inc. Production of microspheres
EP1944016A1 (en) 2001-08-16 2008-07-16 Baxter International Inc. Propellant-based microparticle formulatons
US20030064033A1 (en) * 2001-08-16 2003-04-03 Brown Larry R. Propellant-based microparticle formulations
US7641823B2 (en) * 2001-12-07 2010-01-05 Map Pharmaceuticals, Inc. Synthesis of small particles
JP2005539208A (ja) * 2001-12-21 2005-12-22 スミスクライン ビーチャム コーポレーション グルコース産生を変化させるための組成物および方法
US7677411B2 (en) 2002-05-10 2010-03-16 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
US6985798B2 (en) * 2002-05-10 2006-01-10 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
SI1535349T1 (sl) * 2002-06-27 2014-10-30 Oriel Therapeutics, Inc. Naprave, sistemi in ustrezni postopki za predelavo, izdajo in/ali vrednotenje nefarmacevtskih suhih praškov
US7377277B2 (en) * 2003-10-27 2008-05-27 Oriel Therapeutics, Inc. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
US7451761B2 (en) * 2003-10-27 2008-11-18 Oriel Therapeutics, Inc. Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
WO2005044173A1 (en) 2003-10-27 2005-05-19 Oriel Therapeutics, Inc. Blister packages and associated methods of fabricating dry powder drug containment systems
WO2005065756A2 (en) 2003-12-30 2005-07-21 Oriel Therapeutics, Inc. Dry powder nebulizers and associated methods of dispensing dry powders
US7624733B2 (en) 2004-02-09 2009-12-01 Oriel Therapeutics, Inc. Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
WO2006031775A2 (en) 2004-09-13 2006-03-23 Oriel Therapeutics, Inc. Dry powder inhalers that inhibit agglomeration, related devices and methods
EP1934805A4 (en) * 2005-08-25 2017-01-11 Oriel Therapeutics, Inc. Drug containment systems with sticks, related kits, dry powder inhalers and methods
AU2007210177C1 (en) 2006-01-31 2012-11-01 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP2060268A1 (en) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
MX2011003244A (es) 2008-09-26 2011-04-28 Oriel Therapeutics Inc Inhaladores con discos de vias aereas con canales de vias aereas discretas y discos y metodos relacionados.
MX2011003233A (es) 2008-09-26 2011-04-28 Oriel Therapeutics Inc Inhaladores de polvo seco con miembros de perforacion doble y dispositivos y metodos relacionados.
CA2732826C (en) * 2008-09-26 2017-08-22 Oriel Therapeutics, Inc. Inhaler mechanisms with radially biased piercers and related methods
US8991391B2 (en) * 2008-09-30 2015-03-31 Oriel Therapeutics, Inc. Dry powder inhalers with endless strips and cooperating piercers and related methods
WO2010039201A2 (en) * 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
WO2010039202A2 (en) * 2008-10-01 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with rotating piercing mechanisms and related devices and methods
JP5341532B2 (ja) * 2009-01-19 2013-11-13 第一電子工業株式会社 １対の誤嵌合防止キー及び該キーを用いた電気コネクタ
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
EP2362796A4 (en) 2010-01-27 2014-10-08 Aespira Ltd dry powder inhaler
USD641076S1 (en) 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
USD635246S1 (en) 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
US10238820B2 (en) 2014-01-08 2019-03-26 Seroton, Inc. Dry-powder inhalation device
US11491288B2 (en) 2014-01-08 2022-11-08 Seroton, Inc. Dispenser for dry-powder inhalation devices
WO2024100652A1 (en) 2022-11-07 2024-05-16 Kritzman Kadron Amnon High performance dry powder inhaler

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
NZ232375A (en) * 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
EP0705275B1 (en) * 1993-06-21 1999-02-03 Novo Nordisk A/S Asp-b28 insulin crystals
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
IL118127A0 (en) * 1995-05-05 1996-09-12 Lilly Co Eli Single chain insulin with high bioactivity

Also Published As

Publication number Publication date
EP0951911A2 (en) 1999-10-27
NO20003051D0 (no) 2000-06-14
PL341592A1 (en) 2001-04-23
AU2312299A (en) 1999-07-26
ZA99104B (en) 2000-07-07
CN1287491A (zh) 2001-03-14
EP0951910A2 (en) 1999-10-27
EP0951911A3 (en) 2002-06-19
EP0951910A3 (en) 2002-06-19
PL342745A1 (en) 2001-07-02
AU747619B2 (en) 2002-05-16
HUP0101293A3 (en) 2001-12-28
TR200001891T2 (tr) 2000-11-21
NO20003050D0 (no) 2000-06-14
KR20010033940A (ko) 2001-04-25
AU2107399A (en) 1999-07-26
EA200000747A1 (ru) 2000-12-25
HUP0100391A3 (en) 2001-12-28
HUP0101293A2 (hu) 2001-08-28
CA2317733A1 (en) 1999-07-15
BR9906813A (pt) 2001-03-20
WO1999034816A1 (en) 1999-07-15
US20010053761A1 (en) 2001-12-20
IL137105A0 (en) 2001-06-14
KR20010033941A (ko) 2001-04-25
NO20003051L (no) 2000-06-14
TR200001892T2 (tr) 2000-11-21
WO1999034815A1 (en) 1999-07-15
ZA99105B (en) 2000-07-07
CN1287492A (zh) 2001-03-14
JP2002500192A (ja) 2002-01-08
BR9906796A (pt) 2000-11-14
CA2317739A1 (en) 1999-07-15
JP2002500193A (ja) 2002-01-08
HUP0100391A2 (hu) 2001-08-28
IL137150A0 (en) 2001-07-24
EA200000748A1 (ru) 2000-12-25
US20010007853A1 (en) 2001-07-12
AU754707B2 (en) 2002-11-21
CN1195543C (zh) 2005-04-06

Similar Documents

Publication Publication Date Title
NO20003050D0 (no) Metode for Õ administrere monomere insulinanaloger
NO20010982D0 (no) FremgangsmÕte for Õ administrere insulinotropiske peptider
NO20002038D0 (no) Uløselig insulinsammensetning
DE59909597D1 (de) Verfahren zur kontrolle der insulinmedikation
DE69826705D1 (de) Verfahren zur dermalen verabreichung von polypeptiden
DK1035833T3 (da) Sammensætning til nasal indgivelse
FI963846A (fi) Esitäytetty ruisku, jossa on nokkia
DK1223997T3 (da) Medicinsk infusionssæt
DE69923076D1 (de) Transthorakale arzneimittelabgabevorrichtung
DE69827328D1 (de) Vormontierte Spritze
DK0963211T3 (da) Hypodermisk injektionssystem
DE69829787D1 (de) Verbesserte Injektionsspritze
ZA989744B (en) Method for administering acylated insulin.
PT1283051E (pt) Formulacoes de insulina estaveis
DE69829554D1 (de) Ovalgefortme herzkanüle
DE69919784D1 (de) Spritze
DK0906918T3 (da) Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer
DE69816443D1 (de) Sicherheitsspritze
ID28015A (id) Peningkatan stabilitas larutan injeksi
IT1279684B1 (it) Siringa per iniezioni ipodermiche.
ID20685A (id) Sediaan-sediaan farmasi silansetron yang distabilkan terhadap rasemisasi
NO20006320D0 (no) Cykliske somatostatin-analoger
DE69726820D1 (de) Spritzenpumpe
ID20665A (id) Metode pelarutan karet secara kontinyu
DK1137667T3 (da) GLP-1-analoger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application